1. Hua, Yang, and Xiao Jing. 2019. Executives-employee salary gap, R & D investment intensity and corporate performance—Empirical evidence from Shanghai and Shenzhen A-share new-generation information technology industry listed companies. Chinese Certified Public Accountants 12: 40–44.
2. Wang, Jining, Chong Guo, and Tingqiang Chen. 2020. Empirical study on the transparency of security risk information in Chinese listed pharmaceutical enterprises based on the ANP-DS method. Pubmed, 2020.
3. Milanesi, Matilde, Andrea Runfola, and Simone Guercini. 2020. Pharmaceutical industry riding the wave of sustainability: Review and opportunities for future research. 261.
4. Jandhyala, Ravi. 2020. Influence of pharmaceutical company engagement activities on the decision to prescribe: A pilot survey of UK rare disease medicine prescribers. 34 (1).
5. Yuancong, Ma., Hong Haoqi, and Lin Liqiong. 2019. The effect of financing constraints mitigation on R & D and innovation behavior of small and micro enterprises—An empirical analysis based on survey data of small and micro enterprises in China. Journal of Fujian Agriculture and Forestry University (Philosophy and Social Sciences Edition) 22 (06): 66–77.